PP06. Genetic risk factors for osteoporosis in ukrainian population  by Bezrukov, Vladyslav et al.
 X Congresso Português de Osteoporose 3
ical, hematopoietic and metabolic tasks that result from the close 
interaction between the osteoblast and the osteoclast. Bone emerged 
lately as an endocrine organ controlling the metabolism of glucose. 
More recently, a special attention has been focused on the os-
teoblasts, osteoclasts and osteocytes functions in people with dia-
betes. Some complications of DM may lead to osteoporotic fractures. 
People affected with type 2 DM have increased fracture risk despite 
higher bone mineral density (BMD), as shown by trabecular bone 
score (TBS) and micro indentation of the tibia tests. Type 2 DM also 
results in an increased risk of fracture and delayed fracture healing. 
Since some years ago, some medications for type 2 diabetes were 
associated with an increase in bone fractures. Poor glycemic control 
in type 2 diabetes is associated with increased risk of fragility frac-
tures. Increased longevity and a lifestyle characterized by low phys-
ical activity and high-energy food intake contribute to an increasing 
incidence of DM and osteoporosis. Both osteoporosis and DM have 
high social and financial costs. Hospital inpatient care, medication 
and supplies, retail prescriptions to treat complications, physician 
office visits and paramedical social assistance have high expendi-
tures. The risk for precocious death among those with diabetes is 
about twice that of people with similar age but without diabetes. So, 
these important public health problems, DM and osteoporosis, are 
two of the leading causes of death. Thus, the bone tissue needs to be 
recognized as another important target among the late diabetic 
complications.
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Introduction: Worldwide, osteoporosis and resulting fractures 
constitute a major public health burden with often devastating con-
sequences, leading to increased levels of morbidity and mortality. 
Determination of molecular genetic causes of osteoporosis is a per-
spective approach. There are several methodologies to assess the 
contribution of a candidate gene in the pathogenesis of osteoporosis. 
One of them consists in determining the correlation between allelic 
polymorphism and candidate factors which cause the disease, which 
in comparison estimates allele frequencies of candidate genes in os-
teoporosis patients with individuals not having the disease and pre-
serving normal bone mineral density.
Objectives: To determine the alleles frequency of genes. regula-
tors of bone metabolism in patients with osteoporosis in Ukrainian 
population, and to assess the contribution of different polymor-
phisms in the risk of developing the disease.
Methods: DNA extraction was performed using the phenol-chlo-
roform method from whole blood. Using PCR followed by restriction 
digestion and visualization of the reaction products in polyacryl-
amide gel have been studied 180 patients with osteoporosis and 
160 healthy people of the same age.
Results: We have found association of polymorphism 60890 A/G 
of vitamin D receptor gene (OR = 3.2 (CI95% 2.2-4.6)) and -234 T/G 
polymorphism of collagen type 1 gene (OR = 2.8 (CI95% 2.1-4.1)) with 
the risk of osteoporosis developing. We have not found association 
of polymorphism -764 T/G of estrogen receptor gene (OR = 1,2 (CI95% 
0.6-2.3)).
Conclusions: Knowing association between pathogenic alleles, 
candidate genes and osteoporosis in Ukrainian population will allow 
to use genetic testing to identify predisposition to the disease. The 
results of this study are important for a more rational organization 
of the prevention and treatment of the illness in the early stages of 
disease development.
PP07. OSTEOPOROSIS GENETIC STUDIES IN A SAMPLE 
OF A PORTUGUESE POPULATION
Manuel Bicho1,2, Joana Ferreira1,2, Ana Paula Barbosa2,3,4, 
Mário Rui Mascarenhas2,3,4
1Institute for Scientific Research Bento Rocha Cabral. 2ISAMB, 
Genetics Laboratory, Lisbon Medical School. 3Clinic of Endocrinology, 
Diabetes and Metabolism, Lda. 4Department of Endocrinology, 
Diabetes and Metabolism, Santa Maria Hospital.
Introduction: Several cardiovascular diseases (hypertension di-
abetes, atherosclerosis, heart failure, and chronic kidney diseases) 
have physiopathology pathways in common with osteoporosis.
Objectives: To evaluate the genetic variation in those pathways 
in association studies of osteoporosis.
Methods: The evaluation of osteoporosis and obesity was done in 650 
subjects after measurement of anthropometric parameters like BMI 
(Kg/m2) and BMD (g/cm2) by DEXA. For the stratification of BMD, densi-
tometry was evaluated with QDR Discovery W and the respective soft-
ware 12.02 (Hologic Inc). Genotyping was performed for SNPs, Ins/Del 
and CNVs with PCR, PCR/RFLPs and PAGE technics. Statistics test were 
done with the used of SPSS programme. The analyses of continuous pa-
rameters and discrete data were employed with the appropriate tests.
Results: We studied variation in genes coding proteins belonging 
to acute phase subsystems (Renin–Angiotensin, Haptoglobin-HFE), 
hormonal systems (CYP1A1-COMT), neurotransmitters (5HTLPR, 
5HTVNTR), transducing signals (ACP1 or LMWPTP) and metabolic 
pathways (MTHFR, GSTM and GSTT).
Conclusions: We observed some involvement of those genetic 
polymorphisms in the susceptibility to osteoporosis and its relation-
ship with the metabolic syndrome, not only of individual genes but 
also for epistasis between them.
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Introduction: Several studies discuss the relationship between 
systemic bone mineral density (BMD) and periodontal diseases. Os-
teoporosis or low systemic BMD should be considered as the risk 
factor for periodontal disease progression.
Objectives: The purpose of this study was to determine the im-
pact of bone metabolism – bone formation, on the periodontal status 
in the patients.
Methods: The study included 72 patients (42 men and 30 women, 
mean age – 45.3 ± 6.2 years) with the healthy periodontal status 
(HPS) and 253 patients (145 men and 108 women, mean age – 45.6 ± 
5.2 years) with generalized periodontitis (GP). Clinical conditions of 
periodontal tissue and radiographic determinations (panoramic 
X-Ray) were evaluated. Skeletal systemic BMD was measured by 
DXA. Metabolic processes of bone tissue were evaluated by bone 
turnover markers: bone tissue formation – osteocalcin (OC), 
bone-specific alkaline phosphatase (BAP) in serum.
Results: Comparative analysis of structural and functional state of 
bone tissue in patients showed a mineral density reduction in GP group 
compared to HPS, but these changes were not statistically significant. 
Disorders of bone tissue metabolism were determined in patients with 
GP. The OC level in the patients with GP (18.89 ± 0.87 ng/ml in men and 
20.39 ± 1.14 ng/ml in women) was statistically significantly (p < 0.01) 
lower compared to the HPS group (24.14 ± 1.04 ng/ml in men and 27.56 
± 1.12 ng/ml in women). Decreased levels of bone formation of biochem-
ical bone remodeling markers (BAP) were found in men (19.21 ± 1,76 U/l) 
and women (22.31 ± 1.65 U/l) GP compared to HPS (25. 21 ± 1.76 U/l in 
men and 29,17 ± 1,13 U/l in women, p < 0.05)
